Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18925 | 530 | 45.0 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
607 | 3 | BACULOVIRUS//NUCLEOPOLYHEDROVIRUS//CYTOTECHNOLOGY | 14212 |
1234 | 2 | BACULOVIRUS//NUCLEOPOLYHEDROVIRUS//NUCLEAR POLYHEDROSIS VIRUS | 9056 |
18925 | 1 | BACULOVIRUS//BACMAM//BACULOVIRUS VECTORS | 530 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BACULOVIRUS | authKW | 1083725 | 38% | 9% | 203 |
2 | BACMAM | authKW | 418213 | 3% | 52% | 14 |
3 | BACULOVIRUS VECTORS | authKW | 235246 | 1% | 58% | 7 |
4 | BACULOVIRUS DISPLAY | authKW | 205757 | 1% | 71% | 5 |
5 | PSEUDOTYPE BACULOVIRUS | authKW | 205757 | 1% | 71% | 5 |
6 | GP64 | authKW | 179474 | 2% | 35% | 9 |
7 | BACULOVIRUS TRANSDUCTION | authKW | 172838 | 1% | 100% | 3 |
8 | GP64 ENVELOPE PROTEIN | authKW | 172838 | 1% | 100% | 3 |
9 | WUHAN BIOTECHNOL | address | 135209 | 2% | 18% | 13 |
10 | CHEM MOL SCISTATE VIROL ADV | address | 129627 | 1% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biotechnology & Applied Microbiology | 4248 | 38% | 0% | 202 |
2 | Virology | 3237 | 19% | 0% | 101 |
3 | Medicine, Research & Experimental | 1364 | 20% | 0% | 104 |
4 | Genetics & Heredity | 882 | 18% | 0% | 95 |
5 | Biochemical Research Methods | 293 | 9% | 0% | 46 |
6 | Materials Science, Biomaterials | 270 | 4% | 0% | 21 |
7 | Biochemistry & Molecular Biology | 167 | 19% | 0% | 99 |
8 | Engineering, Biomedical | 98 | 4% | 0% | 21 |
9 | Immunology | 98 | 8% | 0% | 44 |
10 | Dance | 71 | 0% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | WUHAN BIOTECHNOL | 135209 | 2% | 18% | 13 |
2 | CHEM MOL SCISTATE VIROL ADV | 129627 | 1% | 75% | 3 |
3 | LIPOSOME BIOENGN | 129627 | 1% | 75% | 3 |
4 | BULK MFG | 115226 | 0% | 100% | 2 |
5 | MED GENE THER Y UNIT | 115226 | 0% | 100% | 2 |
6 | GENE THER Y UNIT | 90377 | 5% | 7% | 24 |
7 | NANOBIOL NANOMEDSTATE VIROL | 76816 | 0% | 67% | 2 |
8 | BIOTECHNOL MOL MED | 71332 | 4% | 5% | 23 |
9 | BIO OURCE ECT | 60038 | 3% | 7% | 14 |
10 | AGRI ANIM GENET BREEDING | 57613 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TANZ | 19203 | 0% | 33% | 1 |
2 | GENETIC ENGINEERING & BIOTECHNOLOGY NEWS | 16581 | 1% | 5% | 6 |
3 | JOURNAL OF GENE MEDICINE | 14776 | 4% | 1% | 19 |
4 | CURRENT GENE THERAPY | 8498 | 2% | 2% | 9 |
5 | GENE THERAPY | 7099 | 4% | 1% | 22 |
6 | MOLECULAR THERAPY | 6478 | 4% | 1% | 20 |
7 | JOURNAL OF BIOTECHNOLOGY | 3824 | 4% | 0% | 21 |
8 | HUMAN GENE THERAPY | 1712 | 2% | 0% | 10 |
9 | BIOMATERIALS | 1671 | 4% | 0% | 21 |
10 | RECEPTORS & CHANNELS | 1645 | 1% | 1% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BACULOVIRUS | 1083725 | 38% | 9% | 203 | Search BACULOVIRUS | Search BACULOVIRUS |
2 | BACMAM | 418213 | 3% | 52% | 14 | Search BACMAM | Search BACMAM |
3 | BACULOVIRUS VECTORS | 235246 | 1% | 58% | 7 | Search BACULOVIRUS+VECTORS | Search BACULOVIRUS+VECTORS |
4 | BACULOVIRUS DISPLAY | 205757 | 1% | 71% | 5 | Search BACULOVIRUS+DISPLAY | Search BACULOVIRUS+DISPLAY |
5 | PSEUDOTYPE BACULOVIRUS | 205757 | 1% | 71% | 5 | Search PSEUDOTYPE+BACULOVIRUS | Search PSEUDOTYPE+BACULOVIRUS |
6 | GP64 | 179474 | 2% | 35% | 9 | Search GP64 | Search GP64 |
7 | BACULOVIRUS TRANSDUCTION | 172838 | 1% | 100% | 3 | Search BACULOVIRUS+TRANSDUCTION | Search BACULOVIRUS+TRANSDUCTION |
8 | GP64 ENVELOPE PROTEIN | 172838 | 1% | 100% | 3 | Search GP64+ENVELOPE+PROTEIN | Search GP64+ENVELOPE+PROTEIN |
9 | MAMMALIAN GENE TRANSFER | 115226 | 0% | 100% | 2 | Search MAMMALIAN+GENE+TRANSFER | Search MAMMALIAN+GENE+TRANSFER |
10 | TRANSDUCING TITER | 115226 | 0% | 100% | 2 | Search TRANSDUCING+TITER | Search TRANSDUCING+TITER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHEN, CY , LIN, CY , CHEN, GY , HU, YC , (2011) BACULOVIRUS AS A GENE DELIVERY VECTOR: RECENT UNDERSTANDINGS OF MOLECULAR ALTERATIONS IN TRANSDUCED CELLS AND LATEST APPLICATIONS.BIOTECHNOLOGY ADVANCES. VOL. 29. ISSUE 6. P. 618 -631 | 177 | 81% | 39 |
2 | MAKKONEN, KE , AIRENNE, K , YLA-HERTTULALA, S , (2015) BACULOVIRUS-MEDIATED GENE DELIVERY AND RNAI APPLICATIONS.VIRUSES-BASEL. VOL. 7. ISSUE 4. P. 2099 -2125 | 147 | 65% | 3 |
3 | HU, YC , (2008) BACULOVIRAL VECTORS FOR GENE DELIVERY: A REVIEW.CURRENT GENE THERAPY. VOL. 8. ISSUE 1. P. 54 -65 | 126 | 82% | 65 |
4 | AIRENNE, KJ , HU, YC , KOST, TA , SMITH, RH , KOTIN, RM , ONO, C , MATSUURA, Y , WANG, S , YLA-HERTTUALA, S , (2013) BACULOVIRUS: AN INSECT-DERIVED VECTOR FOR DIVERSE GENE TRANSFER APPLICATIONS.MOLECULAR THERAPY. VOL. 21. ISSUE 4. P. 739 -749 | 95 | 69% | 36 |
5 | AIRENNE, KJ , MAKKONEN, KE , MAHONEN, AJ , YLA-HERTTUALA, S , (2010) IN VIVO APPLICATION AND TRACKING OF BACULOVIRUS.CURRENT GENE THERAPY. VOL. 10. ISSUE 3. P. 187-194 | 77 | 83% | 22 |
6 | WANG, S , BALASUNDARAM, G , (2010) POTENTIAL CANCER GENE THERAPY BY BACULOVIRAL TRANSDUCTION.CURRENT GENE THERAPY. VOL. 10. ISSUE 3. P. 214 -225 | 70 | 65% | 30 |
7 | HU, YC , (2006) BACULOVIRUS VECTORS FOR GENE THERAPY.INSECT VIRUSES: BIOTECHNOLOGICAL APPLICATIONS. VOL. 68. ISSUE . P. 287-+ | 70 | 69% | 61 |
8 | PAUL, A , HASAN, A , RODES, L , SANGARALINGAM, M , PRAKASH, S , (2014) BIOENGINEERED BACULOVIRUSES AS NEW CLASS OF THERAPEUTICS USING MICRO AND NANOTECHNOLOGIES: PRINCIPLES, PROSPECTS AND CHALLENGES.ADVANCED DRUG DELIVERY REVIEWS. VOL. 71. ISSUE . P. 115 -130 | 72 | 57% | 3 |
9 | SUNG, LY , CHEN, CL , LIN, SY , LI, KC , YEH, CL , CHEN, GY , LIN, CY , HU, YC , (2014) EFFICIENT GENE DELIVERY INTO CELL LINES AND STEM CELLS USING BACULOVIRUS.NATURE PROTOCOLS. VOL. 9. ISSUE 8. P. 1882 -1899 | 50 | 77% | 10 |
10 | LIN, SY , CHUNG, YC , HU, YC , (2014) UPDATE ON BACULOVIRUS AS AN EXPRESSION AND/OR DELIVERY VEHICLE FOR VACCINE ANTIGENS.EXPERT REVIEW OF VACCINES. VOL. 13. ISSUE 12. P. 1501 -1521 | 87 | 43% | 3 |
Classes with closest relation at Level 1 |